COMMUNIQUÉS West-GlobeNewswire

Aptinyx Reports Positive Data from Phase 1 Study of Novel NMDA Receptor Modulator, NYX-458, in Healthy Volunteers
30/04/2019
Favorable overall safety, tolerability, and pharmacokinetic profile — no serious adverse events reported across wide dose range Achieved ample CNS exposure consistent with exposure observed at preclinically efficacious [...]
Cure Pharmaceutical [OTCQB:CURR] to Present at the “Planet MicroCap Showcase 2019”
30/04/2019
CURE CEO to discuss expanded product pipeline and company’s continued execution into cannabinoid market. LAS VEGAS, April 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and [...]
AGTC to Host Third Quarter Financial Results Conference Call and Webcast on May 7, 2019
30/04/2019
GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]
ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual Meeting
30/04/2019
Eleven relevant presentations are scheduled, covering all five ImprimisRx portfolios SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the ophthalmology-focused pharmaceutical compounding subsidiary of Harrow [...]
Trillium Announces Management and Board Changes and Provides Corporate Update
30/04/2019
TORONTO, April 30, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of [...]
Codexis Signs Multi-Year Enzyme Supply and Licensing Agreement with Tate & Lyle for the Manufacture of TASTEVA® M Stevia Sweetener
30/04/2019
Codexis’ breakthrough enzyme cascade system enables better-tasting stevia product launch REDWOOD CITY, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, [...]
IRADIMED CORPORATION Announces First Quarter 2019 Financial Results
30/04/2019
Reports first quarter 2019 revenue of $8.4 million Reports first quarter 2019 GAAP diluted EPS of $0.15 and non-GAAP diluted EPS of $0.13 WINTER SPRINGS, Fla., April 30, 2019 (GLOBE NEWSWIRE) -- iRadimed Corporation ( [...]
Axovant Announces Dosing of First Patient in Second Cohort of SUNRISE-PD Phase 2 Trial of AXO-Lenti-PD
30/04/2019
-Up to 6 patients to be enrolled in the second cohort, initial data expected in fourth quarter 2019- -Oral presentation at the Annual Meeting of the American Society of Gene and Cell Therapy- BASEL, Switzerland, April [...]
RedHill Biopharma to Host First Quarter 2019 Financial Results Conference Call on May 7, 2019
30/04/2019
TEL-AVIV, Israel and RALEIGH, N.C., April 30, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ( Nasdaq : RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company [...]
Kane Biotech Provides Update on Exclusive License and Distribution Agreement with Dechra Veterinary Products
30/04/2019
Agreement with Dechra leads to Growing Royalty Revenues Following Product Expansion, Growing Sales Demand and Broader Veterinary Approval WINNIPEG, Manitoba, April 30, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: [...]
Teleflex to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
30/04/2019
WAYNE, Pa., April 30, 2019 (GLOBE NEWSWIRE) -- Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Merrill Lynch 2019 Health Care Conference at the Encore Hotel [...]
The Ensign Group Schedules First Quarter 2019 Earnings Call for Tuesday, May 7, 2019
30/04/2019
MISSION VIEJO, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign (TM) group of skilled nursing, rehabilitative care services, assisted living, home health [...]
Amicus Therapeutics Presents Positive Preclinical Pompe Disease Gene Therapy Data at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting
30/04/2019
Preclinical Studies Show Robust Uptake and Glycogen Reduction in Multiple Tissues, Including Brain and Spinal Cord Initial Validation for Collaboration Combining Amicus-Engineered Transgenes with Penn’s AAV Gene Therapy [...]
PCI Biotech: Invitation to first quarter 2019 result presentation
30/04/2019
Oslo, Norway, 30 April 2019 - PCI Biotech invites to a presentation of the company's first quarter 2019 result on Wednesday 8 May 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday 8 May, 08:30am – 09:30am [...]
Capital Senior Living Corporation Announces Release Date for First Quarter 2019 Financial Results
30/04/2019
DALLAS, April 30, 2019 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (NYSE:CSU) will host a conference call with senior management to discuss the Company’s first quarter 2019 financial results. The call will be [...]
Oncology Venture provides news on its clinical development projects dovitinib, 2X‑121 and LiPlaCis
30/04/2019
Press release Hørsholm, Denmark and Cambridge, MA, US, April 30, 2019 – Oncology Venture A/S today provides news on DRP ® based analyses of biopsies from clinical trials with dovitinib. In addition to renal, endometrial [...]
Saniona publishes the Annual Report for 2018
30/04/2019
PRESS RELEASE April 30, 2019 Saniona (OMX: SANION), a biotech company focused on the treatment of eating disorders and diseases of the central nervous system, announced today that the English version of the Annual [...]
BrainStorm’s Cellular Technology Platform Expanded to Include Exosomes for Neurodegenerative Diseases
30/04/2019
NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Brainstorm-Cell Therapeutics Inc. , ( NASDAQ: BCLI ), a leading developer of adult stem cell therapeutics for neurodegenerative disease, today announced that it has expanded [...]
Solo Growth Corp™ Announces Fourth Quarter and Year End 2018 Results and Recent Operational Highlights
30/04/2019
CALGARY, Alberta, April 29, 2019 (GLOBE NEWSWIRE) -- Solo Growth Corp.™ (the “ Company ” or “ Solo Growth ”) (TSXV: SOLO) (WKN:A2PBMC), a cannabis retailer operating as YSS™ with the vision to become a premier retailer [...]

Pages